Blood Marker Could Point to Alzheimer's Risk, Beth Israel Deaconess Medical Center Study
Scientists have zeroed in on blood biomarkers that could someday help doctors predict who's at risk for Alzheimer's disease. They might even help guide treatment, the U.S. researchers added. These biomarkers, called cytokines, are all hallmarks of heightened inflammatory responses. Cytokines specific to Alzheimer's disease were found in greater numbers on white blood cells called mononuclear cells.